Animal Models of Anxiety and Depression: Incorporating the Underlying Mechanisms of Sex Differences in Macroglia Biology
Amy J. Wegener
Gretchen N. Neigh- Department of Anatomy & Neurobiology, Virginia Commonwealth University, Richmond, VA, United States
Animal models have been utilized to explore the mechanisms by which mood disorders develop. Ethologically based stress paradigms are used to induce behavioral responses consistent with those observed in humans suffering from anxiety and depression. While mood disorders are more often diagnosed in women, animal studies are more likely to be carried out in male rodents. However, understanding the mechanisms behind anxiety- and depressive-like behaviors in both sexes is necessary to increase the predictive and construct validity of the models and identify therapeutic targets. To understand sex differences following stress, we must consider how all cell types within the central nervous system are influenced by the neuroendocrine system. This review article discusses the effects of stress and sex steroids on the macroglia: astrocytes and oligodendrocytes. Glia are involved in shaping the synapse through the regulation of neurotransmitter levels and energy resources, making them essential contributors to neural dynamics following stress. As the role of glia in neuromodulation has become more apparent, studies exploring the mechanisms by which glia are altered by stress and steroids will provide insight into sex differences in animal models. These insights will facilitate the optimization of animal models of psychiatric disorders and development of future therapeutic targets.
Introduction
Despite their variety and vast numbers within the central nervous system (CNS), glial cells were initially considered to function only in a supportive capacity to the electrically excitable neurons. However, following decades of research, glial cells have emerged as active contributors to, and modulators of, neuronal activity with functions in neurodevelopment and neuromodulation through the release of gliotransmitters (substances released by glia to facilitate communication) that continuously shape neuronal activity (Allen and Barres, 2005). There are two main classifications of glial cells within the CNS, macroglia and microglia. Two of the major macroglia include astrocytes and oligodendrocytes (Zhou et al., 2020). Astrocytes make up the majority of glial cells within the brain (Eroglu and Barres, 2010). A single astrocyte process may contact up to 100,000 synapses, allowing for direct contact and the ability to influence synaptic communication. Along with microglia, astrocytes are considered to be essential immune cells within the brain, and are involved in neuroinflammation and neurodevelopment through the promotion and maintenance of synapses (Schwarz and Bilbo, 2012). Oligodendrocytes are responsible for producing myelin within the CNS, providing insulation to axons, and increasing the speed of neuronal action potential propagation (Edgar and Sibille, 2012). Increased understanding of the intimate relationship of glia with the synapse has raised the question of how glia may regulate neuronal abnormalities and the development of disorders, as well as serve as potential therapeutic targets (Halassa et al., 2007).
Given the central role of glial in CNS function, it is essential to develop a complete understanding of their contribution to normal and pathological outcomes. One domain in which glial dysfunctions have been implicated is the development of neuropsychiatric disorders, such as anxiety and depression. This may not be surprising considering that canonical pathways dysregulated in these mood disorders include glutamate homeostasis and inflammation, both of which are tightly regulated by glial cells (Kalivas, 2009; Bilbo et al., 2012). Additionally, glia pathology has been recorded in patients that suffered from major depressive disorder (MDD; Miguel-Hidalgo et al., 2000; Rajkowska and Stockmeier, 2013), and astrocyte-oligodendrocyte communication deficits have been implicated in depression, as shown by decreased glia coupling in postmortem brain tissue of male-depressed suicide victims (Tanti et al., 2019). Although complex neuropsychiatric disorders like anxiety and depression cannot be recapitulated in other animals (Dalla et al., 2010), advances in understanding the neurobiology of depression and anxiety have been facilitated by examination of models of chronic stress, a known catalyst of depression and anxiety in humans (Carr et al., 2013). Therefore, this review will focus largely on the impact of chronic stressors on glia biology and function. Finally, we view glia through the lens of sex differences and examine gaps in understanding. While the number of studies evaluating the role of glia in neuropsychiatric disorders has increased, a full understanding of sex differences within these cell-types requires further examination. Women are twice as likely to suffer from anxiety and depression as men (Albert, 2015). However, neuroscience has extensively utilized male rodents in preclinical studies (Mamlouk et al., 2020), including animal models of anxiety- and depressive-like behaviors. The under-representation of females in both clinical and preclinical research leaves a significant gap in the understanding of the biology of mood disorders. Because the topic of sex differences and microglia has been extensively reviewed elsewhere (Bilbo et al., 2012; Bekhbat and Neigh, 2018; Rainville and Hodes, 2019), this review focuses on the macroglia: astrocytes and oligodendrocytes.
Primer on Steroids and The Nervous System
We begin with a brief overview of the influence of steroids in the CNS. Steroids are a class of hormones which are highly lipophilic and are synthesized on demand both by endocrine organs and in the central nervous system (Schmidt et al., 2008; Diotel et al., 2018). The most studied class of steroid receptors are the nuclear receptors which act as transcription factors and thereby can exert profound and long-lasting effects within the brain and periphery (Lösel and Wehling, 2003). Steroids are further subdivided into corticosteroids and sex steroids. The corticosteroids include mineralocorticoids and glucocorticoids and are critical in modulation of circadian functions, such as sleep and feeding behavior (Oster et al., 2006; Dickmeis, 2009), and the response to physical and psychological stressors (Jauregui-Huerta et al., 2010). The sex steroids include progesterone, estrogen, and testosterone. All types of sex steroids exist in both sexes. In addition to the influence of sex steroids over reproductive behaviors and secondary sex characteristics (Morris et al., 2004), sex steroids also influence a wide range of normal and pathological functions unrelated to reproduction.
Chronic and traumatic stress influence the manifestation and progression of mood disorders (McEwen, 2007); therefore, we begin by discussing the interactions among glia and glucocorticoids. Disruptions in homeostasis, whether physical or perceived, activate the hypothalamic-pituitary-adrenal (HPA) axis. This leads to an increase in circulating glucocorticoids (GCs) in the bloodstream that bind to glucocorticoid (GR) and mineralocorticoid receptors (MRs) throughout the organism (McEwen, 2007). HPA axis activation is a normal and healthy response to a perceived threat or physical perturbation; however, continuous HPA axis activation during chronic stress can evoke maladaptive consequences within stress-sensitive brain regions as well as in other organ systems. Although GR binds with lower affinity than MR, GR appears to be more complicit in chronic stress-induced effects. The pervasive impact of GR is at least in part driven by the genomic impact of GR such that activation of the GR can lead to transcriptional changes of up to 10% of genes through glucocorticoid response elements (Jauregui-Huerta et al., 2010). The robust influence of GR is regulated by multiple chaperones and co-chaperones and the effects can be cell-type specific. GR expression has been demonstrated on glia cells within the brain (Vielkind et al., 1990; Bohn et al., 1991). Engagement of the transcriptional influences of steroids is also evident in macroglia. In primary oligodendrocytes cultures isolated from male and female mice, steroid hormones differentially influenced cell survival (Swamydas et al., 2009). Cultured astrocytes respond to corticosterone application with an altered expression of 141 mRNAs, an effect that was attenuated by co-administration with the GR antagonist RU486 (Carter et al., 2012). Additionally, corticosterone treatment in rats resulted in decreased expression of the astrocyte enriched structural protein glial fibrillary acidic protein (GFAP; O’Callaghan et al., 1989; Nichols et al., 1990).
Sex steroids are present in both sexes and differ in concentrations and timing of developmental surges (McCarthy et al., 2002). In addition to the well-known functions of sex steroids in reproductive behaviors and secondary sex characteristics, these steroids catalyze a range of changes in physiology through neuronal actions (McEwen and Parsons, 1982) and influence glial development (McCarthy et al., 2002; Marin-Husstege et al., 2004) and function (Kuo et al., 2010). Importantly, sex steroids and GCs also interact with one another and influence the impact of one another to influence both physiology and behavior (Conrad et al., 2004; Hiroi and Neumaier, 2006) illustrating the centrality of considered sex differences in the examination of stress and related neuropsychiatric disorders. This is particularly important in the context of glial biology because, in addition to the impact of sex steroids on glia through estrogen receptors expressed on both astrocytes and oligodendrocytes (Azcoitia et al., 1999; Takao et al., 2004), glia also influence sex steroid function in that they provide a central source of steroid synthesis. Although peripheral sources of steroids (i.e., ovaries, testes, and adrenals) exert substantial influence in the CNS due to their highly lipophilic nature which facilitates the crossing of the blood-brain barrier, neuroactive steroids can be generated centrally from cholesterol synthesized by astrocytes and oligodendrocytes (Arbo et al., 2016). Thus, sex steroids are positioned to influence a plethora of functions in the brain that are outside the realm of reproductive behaviors.
Astrocytes
The role of astrocytes in neural function, pathology, and repair has provided foundational information for studying the possible role of glia in neuropsychiatric disorders. For instance, progesterone and estrogen have demonstrated neuroprotective effects following injury, inflammation, and stress at the level of glia (Garcia-Ovejero et al., 2005; Arbo et al., 2016). Even in the absence of injury, sex steroids influence astrocyte function. The estrous cycle stage of female rats is associated with glia process ensheathment of synaptic terminals within the arcuate nucleus, with ensheathment decreasing during estrus compared to proestrus (Olmos et al., 1989). Further, the relationship between astrocytes and sex steroids is bidirectional. Glial cells express estrogen receptors and can produce estrogen, thus they can be the driver of estrogen’s protective effects within models of CNS disease (Arevalo et al., 2010). For example, ERα located on astrocytes are responsible for the protective effects of estrogen within a model of autoimmune encephalomyelitis, not neuronal ERα, as seen by decreased levels of macrophage and T-cells of ERα ligand treated animals (Spence et al., 2011).
Although not as easily defined as neural injury studies, a relationship between astrocytes, steroids, and neuropsychiatric disorders has begun to be established. Altered expression of astrocyte density, as seen in post-mortem human tissue, has been implicated in the development of anxiety and depression (Rajkowska and Miguel-Hidalgo, 2007). A similar relationship has been detailed using animal models. Chemically induced deficits of the astrocyte population within the prefrontal cortex (PFC) using the astrocyte toxin L-alpha-aminoadipic acid (L-AAA) induce depressive-like behaviors in rodents (Banasr and Duman, 2008). In addition, exogenous administration of corticosterone, the primary glucocorticoid in rodents, leads to a decrease in the astrocyte structural protein GFAP mRNA (Nichols et al., 1990) and protein (O’Callaghan et al., 1989) within the hippocampus, a stress-sensitive brain region. Changes in GFAP-immunoreactivity (GFAP-IR) may indicate less coverage of the synapse, suggesting a relationship between glucocorticoids and synaptic activity. Changes in cell proliferation rate within the adult CNS can also contribute to altered expression of GFAP positive cells, as seen in male mice that underwent chronic stress and expressed a decreased number of newborn astrocytes in the hippocampus compared to controls (Dioli et al., 2017). In addition, comparison of GFAP-IR in the male Wistar-Kyoto (WKY) rat, which is commonly used as a model in studies of anxiety-like and depressive-like behaviors due to heightened stress-sensitivity, to male Sprague-Dawley rats, found that overall GFAP expression was lower in the PFC, basolateral amygdala (BLA), and hippocampus of the WKY rats (Gosselin et al., 2009). This lower expression of GFAP in stress-sensitive brain regions of the WKY strain suggests that the magnified stress-induced behaviors observed may be due to basal differences in the astrocyte profile within these regions.
While the preceding studies did not include the variable of sex, differences in astrocyte complexity may vary by sex. Ovariectomized (OVX) female rats given estradiol display an increase in GFAP surface density compared to OVX controls in the hippocampus and globus pallidus (Trangue et al., 1987) demonstrating the ability of estradiol to influence astrocytic proteins. In addition, GFAP-IR in the hippocampus of adult Wistar rats was greater in the CA1 region in females, with males displaying greater reactivity in CA3 (Conejo et al., 2003). These findings demonstrate baseline differences in a marker of astrocyte complexity which may be reflective of sex differences in astrocyte phenotype in stress-sensitive brain regions. Further, animal models of stress show sex differences in astrocyte complexity in the medial PFC (mPFC) following chronic stress, results that were sex steroid dependent (Bollinger et al., 2019). This suggests that sex steroids have direct actions on glia activity and may drive sex differences in the glial response to stress, which could facilitate sex differences in behavioral outcomes following stress exposure.
Astrocytes have an established role in neurotransmitter modulation. Importantly, astrocyte-mediated regulation of glutamate basal tone and dysregulation of glutamate homeostasis may contribute to the potentiation of anxiety and depression (Blacker et al., 2019). To this end, the astrocyte enriched glutamate transporter GLT-1 has decreased expression in postmortem tissue obtained from individuals diagnosed with MDD (Choudary et al., 2005; Rajkowska and Stockmeier, 2013). Similarly, preclinical research suggests a role of GLT-1 in behaviors related to mood disorders. Knockout of the GLT-1 gene in astrocyte using male transgenic GFAP-Cre mice results inincreased anxiety-like behaviors in the elevated plus maze (Jia et al., 2020). However, the effects of GLT-1 are region dependent such that deletion of GLT-1 within the lateral habenula increased depressive-like behavior as measured by social interaction and behavior in the novelty-suppressed feeding paradigm (Cui et al., 2014). The brain region specific effects of GLT-1 may also be sex specific. Male and female Long-Evans rats exposed to chronic stress displayed reductions in GLT-1 expression (Rappeneau et al., 2016). However, females had decreased GLT-1 and GFAP mRNA within the PFC and nucleus accumbens (NAc), whereas, males displayed reductions in GLT-1 only in the striatum. Furthermore, comprehensive evaluation of overall glutamate homeostasis in male mice that underwent varying lengths of stress suggests that neuronal and glia protein expression are altered (Nasca et al., 2017). Unfortunately, female mice were not included in this study leaving a gap in knowledge regarding sex differences in glutamate homeostasis following stress which will be important to address given that evidence for differential glutamate homeostasis as a function of sex is evident from postmortem human studies. Analysis of ionotropic and metabotropic glutamate receptor expression in postmortem tissue reveals that females with MDD have higher expression of both receptor classes in the dorsolateral PFC, while males with MDD only display variation in the glutamate metabotropic receptor 5 (GRM5) expression (Gray et al., 2015). While this study focused on neuronal proteins, it suggests there may be sex differences in glutamate homeostasis during the clinical state of depression. Given that astroglia are essential in maintaining glutamate homeostasis and astrocyte-enriched proteins that regulate glutamate clearance are differentially altered in males and females following stress, a comprehensive evaluation of the role of astrocyte enriched protein expression in females following stress will be foundational in building an understanding of the role of astrocytes in the regulation of glutamate homeostasis in the context of both normal brain function and neuropsychiatric disorders.
Oligodendrocytes
White matter consists of oligodendrocytes that ensheath axons and allow neurons to propagate action potentials (Bonnefil et al., 2019). Similar to astrocytes, our understanding of oligodendrocytes and their relationship to steroids was bolstered by the study of neural injury. Examination of a model of autoimmune encephalomyelitis demonstrated that estradiol promotes oligodendrocyte myelin protein survival (Offner and Polanczyk, 2006). Again in line with astrocytes, evidence exists to indicate a relationship between oligodendrocytes and neuropsychiatric diseases. Reductions in white matter are visible in patients with MDD using neuroimaging (Coloigner et al., 2019). Analysis of the anterior cingulate cortex from male victims of suicide with a history of active depression found decreased gap junction coupling between oligodendrocytes and astrocytes, compared to controls (Tanti et al., 2019). Although causality cannot be assessed in this type of study, animal models can be leveraged to investigate how social experience may alter oligodendrocytes and myelinationcreating a risk factor for developing a neuropsychiatric disorder (Toritsuka et al., 2015). Chronic stress in male mice caused morphological changes of oligodendrocytes in the corpus callosum, including increased length of the paranode and juxtaparanode regions and upregulation of multiple adhesion molecules (Miyata et al., 2016) suggesting compromised function. Following chronic social defeat of male mice, the percent area in the NAc covered with myelin basic protein (MBP) is decreased along with the altered length of myelin segmentation in the mPFC (Bonnefil et al., 2019). In the same study, a demyelination compound was directly targeted at the mPFC and decreased social preference in male mice demonstrating that decreasing myelination alone can lead to altered social behavior, similarly to the depletion of astrocytes in the PFC leading to depressive-like behaviors (Banasr and Duman, 2008). Further, male mice that underwent chronic variable stress displayed increased depressive-like behaviors and oligodendrocyte transcriptional changes in the PFC, NAc, amygdala, and corpus callosum (Liu et al., 2018). Thus, changes in oligodendrocyte function are not limited to social stress alone—at least for male organisms as all of the studies discussed excluded females from the analysis.
Despite the frequent exclusion of female subjects from research studies, there is substantial evidence for sex differences in oligodendrocytes. The density and proliferation of oligodendrocytes vary between male and female mice, with adult castrated male mice displaying similar proliferation in the corpus callosum as females which supports a causative role of sex steroids in oligodendrocyte proliferation (Cerghet et al., 2006). This influence of sex on oligodendrocyte proliferation has been confirmed in vitro as demonstrated by greater expression of genes associated with oligodendrocyte proliferation in primary cultures obtained from neonatal female rats compared to males (Yasuda et al., 2020). In addition to basal differences, sex differences in oligodendrocyte markers have been reported following acute stress with differentially altered MBP levels in male and female mice. Male mice displayedincreased levels of MBP in the amygdala and hippocampus 12 days after the stressor (Breton et al., 2020). Conversely, females did not have altered MBP levels until 2 months after the stressor and exhibited increases in the PFC, amygdala, and hippocampus.Thus, the temporal influence of stress on oligodendrocytes differs between the sexes and couldrepresent an important and understudied mechanism driving sex differences in neuropsychiatric diseases.
Antidepressants and Macroglia
There is robust evidence to support the role of glial cells in the development of neuropsychiatric disorders as identified in human post-mortem pathology and the rodent studies discussed. This relationship is further supported by evidence that glial cells are responsive to the influence of some antidepressant treatments. For instance, astrocyte enriched gap junction protein connexin 43 is lowered by chronic unpredictable stress, but the administration of fluoxetine or duloxetine recovered expression deficit in male rats (Sun et al., 2012). In addition, the antidepressant clemastine rescues behavioral deficits and restores MBP coverage in the PFC of socially isolated male mice (Liu et al., 2016). However, antidepressants are not universally efficacious in reversing stress effects on macroglia as evidence of the failure of citalopram to prevent stress-induced reductions of GFAP in astrocytes of male rats (Araya-Callís et al., 2012). These studies did not consider females and illustrate that only partial responsivity of glia to current antidepressants exists. This represents both an opportunity to directly target macroglia in the treatment of mood disorders and the tremendous need to consider females in these assessments.
Conclusions
The goal of this mini-review was to highlight the importance of sex in the consideration of the role of macroglia in mental health disorders and altered affective-like behaviors. Glia are involved in shaping the synapse through the regulation of neurotransmitter levels and energy resources, making them essential contributors to neural dynamics following stress. We have highlighted astrocytes and oligodendrocytes, both of which are implicated in the progression of MDD (Figure 1). To date, studies have focused on the role of glia or neuronal proteins in the progression of anxiety and depression; however, opportunities to identify expression variations in multiple cell types within a single condition or preclinical model could elucidate the overall change in tone at the synapse and provide an important contribution to advancing our understanding. Additionally, assessment of glia-glia communication following stress will be a critical area of future study in order to determine how macroglia change the dynamics of neural resources and overall communication. Furthermore, as the role of glia in neuromodulation continues to be elucidated, studies exploring the mechanisms by which glia are altered by stress and steroids will provide insight into sex differences in animal models and inform our understanding of sex differences in the clinical setting. Finally, clarification of macroglia function in health and disease in both sexes will provide the foundation for novel mechanistic interventions that may have the capacity to treat beyond the symptoms and target the biological nexus from which symptoms manifest.
Figure 1. Within the CNS, glia cells are positioned in close contact with neighboring neurons. This positioning allows the glial cells to tightly control the environment and facilitate neuronal communication. Following stress, this regulation can become dysregulated. Key proteins involved in astrocyte function are downregulated leading to decreased cradling at the synapse and altered glutamate homeostasis. Oligodendrocytes will experience downregulation of the key myelin basic protein and altered wrapping at the neuronal axon. Preclinical works suggest protein dysregulation following stress is different between males and females, but more work is needed to understand these mechanisms. *Microglia are intimately associated with the synapse and other nearby glia cells. The interactions between microglia and neurons can be disrupted following stress. While microglia are not discussed in this review, other reviews have extensively outlined the ways microglia contribute to sex differences in the stress response (Bilbo et al., 2012; Bekhbat and Neigh, 2018; Rainville and Hodes, 2019). Created with Biorender.com.
Author Contributions
GN and AW decided on the topic area together. AW drafted the first draft of the review with guidance from GN. GN revised and edited the review. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Albert, P. R. (2015). Why is depression more prevalent in women? J. Psychiatry Neurosci. 40, 219–221. doi: 10.1503/jpn.150205
Allen, N. J., and Barres, B. A. (2005). Signaling between glia and neurons: focus on synaptic plasticity. Curr. Opin. Neurobiol. 15, 542–548. doi: 10.1016/j.conb.2005.08.006
Araya-Callís, C., Hiemke, C., Abumaria, N., and Flugge, G. (2012). Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology (Berl) 224, 209–222. doi: 10.1007/s00213-012-2741-x
Arbo, B. D., Bennetti, F., and Ribeiro, M. F. (2016). Astrocytes as a target for neuroprotection: modulation by progesterone and dehydroepiandrosterone. Prog. Neurobiol. 144, 27–47. doi: 10.1016/j.pneurobio.2016.03.010
Arevalo, M. A., Santos-Galindo, M., Bellini, M. J., Azcoitia, I., and Garcia-Segura, L. M. (2010). Actions of estrogens on glial cells: Implications for neuroprotection. Biochim. Biophys. Acta 1800, 1106–1112. doi: 10.1016/j.bbagen.2009.10.002
Azcoitia, I., Sierra, A., and Garcia-Segura, L. M. (1999). Localization of estrogen receptor beta-immunoreactivity in astrocytes of the adult rat brain. Glia 26, 260–267. doi: 10.1002/(SICI)1098-1136(199905)26:3<260::AID-GLIA7>3.0.CO;2-R
Banasr, M., and Duman, R. S. (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol. Psychiatry 64, 863–870. doi: 10.1016/j.biopsych.2008.06.008
Bekhbat, M., and Neigh, G. N. (2018). Sex differences in the neuro-immune consequences of stress: focus on depression and anxiety. Brain Behav. Immun. 67, 1–12. doi: 10.1016/j.bbi.2017.02.006
Bilbo, S. D., Smith, S. H., and Schwarz, J. M. (2012). A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia. J. Neuroimmune Pharmacol. 7, 24–41. doi: 10.1007/s11481-011-9299-y
Blacker, C. J., Millischer, V., Webb, L. M., Ho, A. M. C., Schalling, M., Frye, M. A., et al. (2019). EAAT2 as a research target in bipolar disorder and unipolar depression: a systematic review. Mol. Neuropsychiatry 5, 44–59. doi: 10.1159/000501885
Bohn, M. C., Howard, E., Vielkind, U., and Krozowski, Z. (1991). Glial cells express both mineralocorticoid and glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 40, 105–111. doi: 10.1016/0960-0760(91)90173-3
Bollinger, J. L., Salinas, I., Fender, E., Sengelaub, D. R., and Wellman, C. L. (2019). Gonadal hormones differentially regulate sex-specific stress effects on glia in the medial prefrontal cortex. J. Neuroendocrinol. 31:e12762. doi: 10.1111/jne.12762
Bonnefil, V., Dietz, K., Amatruda, M., Wentling, M., Aubry, A. V., Dupree, J. L., et al. (2019). Region-specific myelin differences define behavioral consequences of chronic social defeat stress in mice. eLife 8:e40855. doi: 10.7554/eLife.40855
Breton, J. M., Barraza, M., Hu, K. Y., Frias, S. J., Long, K. L. P., and Kaufer, D. (2020). Juvenile exposure to acute traumatic stress leads to long-lasting alterations in grey matter myelination in adult female but not male rats. BioRxiv [Preprint]. doi: 10.1101/2020.12.14.422686
Carr, C. P., Martins, C. M. S., Stingel, A. M., Lemgruber, V. B., and Juruena, M. F. (2013). The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes. J. Nerv. Ment. Dis. 201, 1007–1020. doi: 10.1097/NMD.0000000000000049
Carter, B. S., Meng, F., and Thompson, R. C. (2012). Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro. Physiol. Genomics 44, 1188–1200. doi: 10.1152/physiolgenomics.00097.2012
Cerghet, M., Skoff, R. P., Bessert, D., Zhang, Z., Mullins, C., and Ghandour, M. S. (2006). Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 26, 1439–1447. doi: 10.1523/JNEUROSCI.2219-05.2006
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., et al. (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U S A 102, 15653–15658. doi: 10.1073/pnas.0507901102
Coloigner, J., Batail, J. M., Commowick, O., Corouge, I., Robert, G., Barillot, C., et al. (2019). White matter abnormalities in depression: a categorical and phenotypic diffusion MRI study. Neuroimage Clin. 22:101710. doi: 10.1016/j.nicl.2019.101710
Conejo, N. M., González-Pardo, H., Pedraza, C., Navarro, F. F., Vallejo, G., and Arias, J. L. (2003). Evidence for sexual difference in astrocytes of adult rat hippocampus. Neurosci. Lett. 339, 119–122. doi: 10.1016/s0304-3940(02)01484-2
Conrad, C. D., Jackson, J. L., Wieczorek, L., Baran, S. E., Harman, J. S., Wright, R. L., et al. (2004). Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacol. Biochem. Behav. 78, 569–579. doi: 10.1016/j.pbb.2004.04.025
Cui, W., Mizukami, H., Yanagisawa, M., Aida, T., Nomura, M., Isomura, Y., et al. (2014). Glial dysfunction in the mouse habenula causes depressive-like behaviors and sleep disturbance. J. Neurosci. 34, 16273–16285. doi: 10.1523/JNEUROSCI.1465-14.2014
Dalla, C., Pitychoutis, P. M., Kokras, N., and Papadopoulou-Daifoti, Z. (2010). Sex differences in animal models of depression and antidepressant response. Basic Clin. Pharmacol. Toxicol. 106, 226–233. doi: 10.1111/j.1742-7843.2009.00516.x
Dickmeis, T. (2009). Glucocorticoids and the circadian clock. J. Endocrinol. 200, 3–22. doi: 10.1677/JOE-08-0415
Dioli, C., Patrício, P., Trindade, R., Pinto, L. G., Silva, J. M., Morais, M., et al. (2017). Tau-dependent suppression of adult neurogenesis in the stressed hippocampus. Mol. Psychiatry 22, 1110–1118. doi: 10.1038/mp.2017.103
Diotel, N., Charlier, T. D., Lefebvre d’Hellencourt, C., Couret, D., Trudeau, V. L., Nicolau, J. C., et al. (2018). Steroid transport, local synthesis and signaling within the brain: Roles in neurogenesis, neuroprotection and sexual behaviors. Front. Neurosci. 12:84. doi: 10.3389/fnins.2018.00084
Edgar, N., and Sibille, E. (2012). A putative functional role for oligodendrocytes in mood regulation. Transl. Psychiatry 2:e109. doi: 10.1038/tp.2012.34
Eroglu, C., and Barres, B. A. (2010). Regulation of synaptic connectivity by glia. Nature 468, 223–231. doi: 10.1038/nature09612
Garcia-Ovejero, D., Azcoitia, I., DonCarlos, L. L., Melcangi, R. C., and Garcia-Segura, L. M. (2005). Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Rev. 48, 273–286. doi: 10.1016/j.brainresrev.2004.12.018
Gosselin, R. D., Gibney, S., O’Malley, D., Dinan, T. G., and Cryan, J. F. (2009). Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 159, 915–925. doi: 10.1016/j.neuroscience.2008.10.018
Gray, A. L., Hyde, T. M., Deep-Soboslay, A., Kleinman, J. E., and Sodhi, M. S. (2015). Sex differences in glutamate receptor gene expression in major depression and suicide. Mol. Psychiatry 20, 1057–1068. doi: 10.1038/mp.2015.91
Halassa, M. M., Fellin, T., and Haydon, P. G. (2007). The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 13, 54–63. doi: 10.1016/j.molmed.2006.12.005
Hiroi, R., and Neumaier, J. F. (2006). Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav. Brain Res. 166, 93–100. doi: 10.1016/j.bbr.2005.07.021
Jauregui-Huerta, F., Ruvalcaba-Delgadillo, Y., Gonzalez-Perez, O., Gonzalez-Castaneda, R., Garcia-Estrada, J., and Luquin, S. (2010). Responses of glial cells to stress and glucocorticoids. Curr. Immunol. Rev. 6, 195–204. doi: 10.2174/157339510791823790
Jia, Y. F., Wininger, K., Ho, A. M. C., Peyton, L., Baker, M., and Choi, D. S. (2020). Astrocytic glutamate transporter 1 (GLT1) deficiency reduces anxiety- and depression-like behaviors in mice. Front. Behav. Neurosci. 14:57. doi: 10.3389/fnbeh.2020.00057
Kalivas, P. W. (2009). The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10, 561–572. doi: 10.1038/nrn2515
Kuo, J., Hamid, N., Bondar, G., Dewing, P., Clarkson, J., and Micevych, P. (2010). Sex differences in hypothalamic astrocyte response to estradiol stimulation. Biol. Sex Differ. 1:7. doi: 10.1186/2042-6410-1-7
Liu, J., Dietz, K., Hodes, G. E., Russo, S. J., and Casaccia, P. (2018). Widespread transcriptional alternations in oligodendrocytes in the adult mouse brain following chronic stress. Dev. Neurobiol. 78, 152–162. doi: 10.1002/dneu.22533
Liu, J., Dupree, J. L., Gacias, M., Frawley, R., Sikder, T., Naik, P., et al. (2016). Clemastine enhances myelination in the prefrontal cortex and rescues behavioral changes in socially isolated mice. J. Neurosci. 36, 957–962. doi: 10.1523/JNEUROSCI.3608-15.2016
Lösel, R., and Wehling, M. (2003). Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 4, 46–56. doi: 10.1038/nrm1009
Mamlouk, G. M., Dorris, D. M., Barrett, L. R., and Meitzen, J. (2020). Sex bias and omission in neuroscience research is influenced by research model and journal, but not reported NIH funding. Front. Neuroendocrinol. 57:100835. doi: 10.1016/j.yfrne.2020.100835
Marin-Husstege, M., Muggironi, M., Raban, D., Skoff, R. P., and Casaccia-Bonnefil, P. (2004). Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 26, 245–254. doi: 10.1159/000082141
McCarthy, M. M., Amateau, S. K., and Mong, J. A. (2002). Steroid modulation of astrocytes in the neonatal brain: implications for adult reproductive function. Biol. Reprod. 67, 691–698. doi: 10.1095/biolreprod.102.003251
McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873–904. doi: 10.1152/physrev.00041.2006
McEwen, B. S., and Parsons, B. (1982). Gonadal steroid action on the brain: neurochemistry and neuropharmacology. Annu. Rev. Pharmacol. Toxicol. 22, 555–598. doi: 10.1146/annurev.pa.22.040182.003011
Miguel-Hidalgo, J. J., Baucom, C., Dilley, G., Overholser, J. C., Meltzer, H. Y., Stockmeier, C. A., et al. (2000). Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol. Psychiatry 48, 861–873. doi: 10.1016/s0006-3223(00)00999-9
Miyata, S., Taniguchi, M., Koyama, Y., Shimizu, S., Tanaka, T., Yasuno, F., et al. (2016). Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression. Sci. Rep. 6:23084. doi: 10.1038/srep23084
Morris, J. A., Jordan, C. L., and Breedlove, S. M. (2004). Sexual differentiation of the vertebrate nervous system. Nat. Neurosci. 7, 1034–1039. doi: 10.1038/nn1325
Nasca, C., Bigio, B., Zelli, D., de Angelis, P., Lau, T., Okamoto, M., et al. (2017). Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress. Neuron 96, 402–413.e5. doi: 10.1016/j.neuron.2017.09.020
Nichols, N. R., Osterburg, H. H., Masters, J. N., Millar, S. L., and Finch, C. E. (1990). Messenger RNA for glial fibrillary acidic protein is decreased in rat brain following acute and chronic corticosterone treatment. Brain Res. Mol. Brain Res. 7, 1–7. doi: 10.1016/0169-328x(90)90066-m
O’Callaghan, J. P., Brinton, R. E., and McEwen, B. S. (1989). Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain. Brain Res. 494, 159–161. doi: 10.1016/0006-8993(89)90156-x
Offner, H., and Polanczyk, M. (2006). A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N Y Acad. Sci. 1089, 343–372. doi: 10.1196/annals.1386.021
Olmos, G., Naftolin, F., Perez, J., Tranque, P. A., and Garcia-Segura, L. M. (1989). Synaptic remodeling in the rat arcuate nucleus during the estrous cycle. Neuroscience 32, 663–667. doi: 10.1016/0306-4522(89)90288-1
Oster, H., Damerow, S., Kiessling, S., Jakubcakova, V., Abraham, D., Tian, J., et al. (2006). The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 4, 163–173. doi: 10.1016/j.cmet.2006.07.002
Rainville, J. R., and Hodes, G. E. (2019). Inflaming sex differences in mood disorders. Neuropsychopharmacology 44, 184–199. doi: 10.1038/s41386-018-0124-7
Rajkowska, G., and Miguel-Hidalgo, J. (2007). Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 6, 219–233. doi: 10.2174/187152707780619326
Rajkowska, G., and Stockmeier, C. A. (2013). Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 14, 1225–1236. doi: 10.2174/13894501113149990156
Rappeneau, V., Blaker, A., Petro, J. R., Yamamoto, B. K., and Shimamoto, A. (2016). Disruption of the glutamate-glutamine cycle involving astrocytes in an animal model of depression for males and females. Front. Behav. Neurosci. 10:231. doi: 10.3389/fnbeh.2016.00231
Schmidt, K. L., Pradhan, D. S., Shah, A. H., Charlier, T. D., Chin, E. H., and Soma, K. K. (2008). Neurosteroids, immunosteroids and the Balkanization of endocrinology. Gen. Comp. Endocrinol. 157, 266–274. doi: 10.1016/j.ygcen.2008.03.025
Schwarz, J. M., and Bilbo, S. D. (2012). Sex, glia and development: interactions in health and disease. Horm. Behav. 62, 243–253. doi: 10.1016/j.yhbeh.2012.02.018
Spence, R. D., Hamby, M. E., Umeda, E., Itoh, N., Du, S., Wisdom, A. J., et al. (2011). Neuroprotection mediated through estrogen receptor-α in astrocytes. Proc. Natl. Acad. Sci. U S A 108, 8867–8872. doi: 10.1073/pnas.1103833108
Sun, J. D., Liu, Y., Yuan, Y. H., Li, J., and Chen, N. H. (2012). Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 37, 1305–1320. doi: 10.1038/npp.2011.319
Swamydas, M., Bessert, D., and Skoff, R. (2009). Sexual dimorphism of oligodendrocytes is mediated by differential regulation of signaling pathways. J. Neurosci. Res. 87, 3306–3319. doi: 10.1002/jnr.21943
Takao, T., Flint, N., Lee, L., Ying, X., Merrill, J., and Chandross, K. J. (2004). 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J. Neurochem. 89, 660–673. doi: 10.1111/j.1471-4159.2004.02370.x
Tanti, A., Lutz, P. E., Kim, J., O’Leary, L., Théroux, J. F., Turecki, G., et al. (2019). Evidence of decreased gap junction coupling between astrocytes and oligodendrocytes in the anterior cingulate cortex of depressed suicides. Neuropsychopharmacology 44, 2099–2111. doi: 10.1038/s41386-019-0471-z
Toritsuka, M., Makinodan, M., and Kishimoto, T. (2015). Social experience-dependent myelination: an implication for psychiatric disorders. Neural Plast. 2015:465345. doi: 10.1155/2015/465345
Trangue, P. A., Suarez, I., Olmos, G., Fernandez, B., and Garcia-Segura, L. M. (1987). Estradiol - induced redistribution of glial fibrillary acidic protein immunoreactivity in the rat brain. Brain Res. 406, 348–351. doi: 10.1016/0006-8993(87)90805-5
Vielkind, U., Walencewicz, A., Levine, J. M., and Bohn, M. C. (1990). Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes. J. Neurosci. Res. 27, 360–373. doi: 10.1002/jnr.490270315
Yasuda, K., Maki, T., Kinoshita, H., Kaji, S., Toyokawa, M., Nishigori, R., et al. (2020). Sex-specific differences in transcriptomic profiles and cellular characteristics of oligodendrocyte precursor cells. Stem Cell Res. 46:101866. doi: 10.1016/j.scr.2020.101866
Keywords: glia, astrocytes, oligodendrocytes, stress, anxiety, depression, sex differences
Citation: Wegener AJ and Neigh GN (2021) Animal Models of Anxiety and Depression: Incorporating the Underlying Mechanisms of Sex Differences in Macroglia Biology. Front. Behav. Neurosci. 15:780190. doi: 10.3389/fnbeh.2021.780190
Received: 20 September 2021; Accepted: 11 November 2021;
Published: 09 December 2021.
Edited by:
Nikolaos Kokras, National and Kapodistrian University of Athens, GreeceReviewed by:
Ioannis Sotiropoulos, University of Minho, PortugalMarianne Seney, University of Pittsburgh, United States
Copyright © 2021 Wegener and Neigh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gretchen N. Neigh, gretchen.mccandless@vcuhealth.org